Skip to main content
. Author manuscript; available in PMC: 2019 Nov 25.
Published in final edited form as: Vaccine. 2019 Jun 11;37(30):4184–4194. doi: 10.1016/j.vaccine.2019.04.071

Table 2.

Complete list of vectors and plasmids used in the study.

Plasmid Protein (s) Function
pCAGGS None Expression vector
pCAGGS-gpK8.1-gB-gL-gH −HR2 KSHV glycoproteins, K8.1, gB, gH and gL without
NDV F protein heptad repeat 2 domain
VLP production
pCAGGS-gpK8.1-gB-gL-gH+HR2 KSHV glycoproteins, K8.1, gB, gH, gL and
NDV F protein heptad repeat 2 domain
VLP production
pCAGGS-NDV NP NDV nucleocapsid protein VLP production
pCAGGS-NDV M NDV matrix protein VLP production
pCAGGS-NP LANA1 Truncated KSHV latent associated nuclear antigen Immunoblot
pCAGGS-LANA1 KSHV wild type latent associated nuclear antigen Immunoblot
pCAGGS-gpK8.1 KSHV glycoprotein K8.1 Stable cell production/ protein production
pCAGGS-gB KSHV glycoprotein gB Soluble protein production
pCAGGS-gH/gL KSHV glycoproteins gH and gL Soluble protein production
pCMVi-SV40ori-Fc-His None Expression vector
pCMVi-SV40ori-gpK8.1-Fc-6xHis KSHV glycoprotein K8.1 Soluble protein production
pCMVi-SV40ori-gB-Fc-6xHis KSHV glycoprotein gB Soluble protein production
pCMVi-SV40ori-gH/gL- Fc-6xHis KSHV glycoproteins gH and gL Soluble protein production